NCT05517291

DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease

Paclitaxel Coated Balloon Angioplasty Versus Primary Selective Stenting in the Treatment of TASC C/D Chronic Femoropopliteal Artery Occlusive Disease: A Multicenter Randomized Clinical Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This study aims to compare the mid- and long-term outcomes between paclitaxel-coated balloon and primary selective stenting in the treatment of TASC C/D femoropopliteal artery occlusive disease.

Conditions

• Safety Issues
• Efficacy, Self

Interventions

Type	Name	Description
DEVICE	paclitaxel-coated balloon angioplasty or bare mental stents implantation	paticipants who enrolled in this study will received paclitaxel-coated balloon angioplasty plus bailout stenting or primary bare mental stents implantation randomly

Timeline

• Start date: 2022-09-18
• Primary completion: 2024-12-31
• Completion: 2027-12-31
• First posted: 2022-08-26
• Last updated: 2022-12-06

Locations

1 site across 1 country: China